Roth MKM Maintains Buy on Bioceres Crop Solutions, Lowers Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Roth MKM analyst Brian Wright maintains a Buy rating on Bioceres Crop Solutions (NASDAQ:BIOX) but lowers the price target from $31 to $20.
November 01, 2023 | 3:47 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Despite the lowered price target for Bioceres Crop Solutions (BIOX) from $31 to $20, Roth MKM analyst Brian Wright maintains a Buy rating on the stock.
The news is directly about Bioceres Crop Solutions (BIOX). The lowered price target might cause some investors to sell, putting downward pressure on the stock. However, the maintained Buy rating indicates that the analyst still sees potential in the company, which could counteract some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100